Parkinson's disease-cognitive cognitive scale specific for rating scale: A new Parkinson's disease

被引:260
|
作者
Pagonabarraga, Javier
Kulisevsky, Jaime [1 ]
Llebaria, Gisela
Garcia-Sanchez, Carmen
Pascual-Sedano, Berta
Gironell, Alexandre
机构
[1] Autonomous Univ Barcelona, St Pau Hosp, Movement Disorders Unit, Dept Neurol, Barcelona 08025, Spain
关键词
Parkinson's disease; cognition; dementia; rating scale; neuropsychological;
D O I
10.1002/mds.22007
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Cognitive defects associated with cortical pathology may be a marker of dementia in Parkinson's disease (PD). There is a need to improve the diagnostic criteria of PD dementia (PDD) and to clarify the cognitive impairment patterns associated with PD. Current neuropsychological batteries designed for PD are focused on fronto-subcortical deficits but are not sensitive for cortical dysfunction. We developed a new scale, the Parkinson's Disease-Cognitive Rating Scale (PDCRS), that was designed to cover the full spectrum of cognitive defects associated with PD. We prospectively studied 92 PD patients [30 cognitively intact (CogInt), 30 mild cognitive impairment (MCI), 32 PDD] and 61 matched controls who completed the PD-CRS and neuropsychological tests assessing the cognitive domains included in the PD-CRS. Acceptability, construct validity, reliability, and the discriminative properties of the PD-CRS were examined. The PD-CRS included items assessing fronto-subcortical defects and items assessing cortical dysfunction. Construct validity, test-retest and inter-rater reliability of PD-CRS total scores showed an intraclass correlation coefficient > 0.70. The PD-CRS showed an excellent test accuracy to diagnose PDD (sensitivity 94%, specificity 94%). The PD-CRS total scores and confrontation naming item scores-assessing "cortical" dysfunction-independently differentiated PDD from non-demented PD. Alternating verbal fluency and delayed verbal memory independently differentiated the MCI group from both controls and CogInt. The PD-CRS appeared to be a reliable and valid PD-specific battery that accurately diagnosed PDD and detected subtle fronto-subcortical deficits. Performance on the PD-CRS showed that PDD is characterized by the addition of cortical dysfunction upon a predominant and progressive fronto-subcortical impairment. (c) 2008 Movement Disorder Society.
引用
收藏
页码:998 / 1005
页数:8
相关论文
共 50 条
  • [21] Detection of Parkinson's Disease Using Rating Scale
    Banita
    2020 INTERNATIONAL CONFERENCE ON COMPUTATIONAL PERFORMANCE EVALUATION (COMPE-2020), 2020, : 121 - 125
  • [22] Comparison of the unified Parkinson's disease rating scale and the short Parkinson's evaluation scale in patients with Parkinson's disease after levodopa loading
    Rabey, JM
    Klein, C
    Molochnikov, A
    Van Hilten, B
    Krauss, P
    Bonuccelli, U
    CLINICAL NEUROPHARMACOLOGY, 2002, 25 (02) : 83 - 88
  • [23] Psychometric Properties of the Clinical Dementia Rating Scale Sum of Boxes in Parkinson's Disease
    Gallagher, Julia
    Rick, Jacqueline
    Xie, Sharon X.
    Martinez-Martin, Pablo
    Mamikonyan, Eugenia
    Chen-Plotkin, Alice
    Dahodwala, Nabila
    Morley, James
    Duda, John E.
    Trojanowski, John Q.
    Siderowf, Andrew
    Weintraub, Daniel
    JOURNAL OF PARKINSONS DISEASE, 2021, 11 (02) : 737 - 745
  • [24] Parkinson's disease severity levels and MDS-Unified Parkinson's Disease Rating Scale
    Martinez-Martin, Pablo
    Rodriguez-Blazquez, Carmen
    Alvarez, Mario
    Arakaki, Tomoko
    Campos Arillo, Victor
    Chana, Pedro
    Fernandez, William
    Garretto, Nelida
    Carlos Martinez-Castrillo, Juan
    Rodriguez-Violante, Mayela
    Serrano-Duenas, Marcos
    Ballesteros, Diego
    Manuel Rojo-Abuin, Jose
    Chaudhuri, Kallol Ray
    Merello, Marcelo
    PARKINSONISM & RELATED DISORDERS, 2015, 21 (01) : 50 - 54
  • [25] Cognitive Training in Parkinson's Disease - A New Therapy Option?
    Kalbe, E.
    Folkerts, A. -K.
    FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2016, 84 : S24 - S35
  • [26] A Recommended Scale for Cognitive Screening in Clinical Trials of Parkinson's Disease
    Chou, Kelvin L.
    Amick, Melissa M.
    Brandt, Jason
    Camicioli, Richard
    Frei, Karen
    Gitelman, Darren
    Goldman, Jennifer
    Growdon, John
    Hurtig, Howard I.
    Levin, Bonnie
    Litvan, Irene
    Marsh, Laura
    Simuni, Tanya
    Troester, Alexander I.
    Uc, Ergun Y.
    MOVEMENT DISORDERS, 2010, 25 (15) : 2501 - 2507
  • [27] Scale consistance in cognitive status awareness of patients with Parkinson's disease
    Aydemir, Sabiha Tezcan
    Unutmaz, Elif Yusra
    Ozkan, Pinar
    Abali, Talha
    Ayik, Gulnur
    Batmaz, Dudu Genc
    Kibrit, Sema Nur
    Karacan, Ahmet Veli
    Kumcu, Muge Kuzu
    Yekeduc, Merve Koc
    Eminoglu, Fatma Tuba
    Yilmaz, Rezzak
    Akbostanci, Muhittin Cenk
    TURKISH JOURNAL OF NEUROLOGY, 2024, 30 (03) : 185 - 189
  • [28] Mild cognitive impairment in Parkinson's disease
    Martinez-Horta, Saul
    Kulisevsky, Jaime
    JOURNAL OF NEURAL TRANSMISSION, 2019, 126 (07) : 897 - 904
  • [29] Cognitive dysfunction and dementia in Parkinson's disease
    Bosboom, JLW
    Stoffers, D
    Wolters, EC
    JOURNAL OF NEURAL TRANSMISSION, 2004, 111 (10-11) : 1303 - 1315
  • [30] Progression of Cognitive Decline in Parkinson's Disease
    Roheger, Mandy
    Kalbe, Elke
    Liepelt-Scarfone, Inga
    JOURNAL OF PARKINSONS DISEASE, 2018, 8 (02) : 183 - 193